AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM Drug Patent Profile
✉ Email this page to a colleague
When do Amlodipine Besylate And Atorvastatin Calcium patents expire, and when can generic versions of Amlodipine Besylate And Atorvastatin Calcium launch?
Amlodipine Besylate And Atorvastatin Calcium is a drug marketed by Apotex, Dr Reddys, Mylan, and Zydus Pharms. and is included in four NDAs.
The generic ingredient in AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM is amlodipine besylate; atorvastatin calcium. There are fifty drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the amlodipine besylate; atorvastatin calcium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Amlodipine Besylate And Atorvastatin Calcium
A generic version of AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM was approved as amlodipine besylate; atorvastatin calcium by MYLAN on November 29th, 2013.
Summary for AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 4 |
| Finished Product Suppliers / Packagers: | 6 |
| Clinical Trials: | 3 |
| Formulation / Manufacturing: | see details |
| What excipients (inactive ingredients) are in AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM? | AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM excipients list |
| DailyMed Link: | AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM at DailyMed |
Recent Clinical Trials for AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Alphacait, LLC | Phase 2 |
| Haining Health-Coming Biotech Co., Ltd. | Phase 2 |
| Dr. Reddy's Laboratories Limited | Phase 1 |
See all AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM clinical trials
Pharmacology for AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
Anatomical Therapeutic Chemical (ATC) Classes for AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
US Patents and Regulatory Information for AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zydus Pharms | AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | amlodipine besylate; atorvastatin calcium | TABLET;ORAL | 207762-011 | Jan 11, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Zydus Pharms | AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | amlodipine besylate; atorvastatin calcium | TABLET;ORAL | 207762-002 | Jan 11, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Mylan | AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | amlodipine besylate; atorvastatin calcium | TABLET;ORAL | 200465-009 | Nov 29, 2013 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
